The Australian Register of Therapeutic Goods (ARTG) listing is the mandatory pathway for legally supplying medical devices in Australia. Successfully achieving this listing requires understanding the distinct stages overseen by the TGA.
This overview outlines the essential steps sponsors must follow to navigate the entire ARTG registration process and obtain market authorisation.
Device Classification and Documentation
The first critical stage is device classification. Devices are categorised based on intended use and risk level (Classes I, IIa, IIb, III, and AIMD), which determines the required regulatory effort. Sponsors must ensure the device complies with the Essential Principles, covering aspects like design, manufacture, quality, and safety.
Sponsors must ensure the device complies with the Essential Principles (covering design, quality, and safety) and compile a comprehensive Technical File. This file must contain evidence like manufacturing information, risk management files, labelling, and clinical evidence to substantiate performance.
Submission and Compliance
The sponsor must submit a formal application for ARTG inclusion for medical devices through the TGA’s electronic system, declaring compliance and providing evidence details. For higher-risk devices, the TGA may conduct a mandatory review of the conformity assessment. Once approved, the device is entered onto the ARTG. This listing immediately triggers ongoing obligations related to post-market surveillance and continued compliance throughout the device’s lifecycle.
Beyond the Initial Listing
Achieving ARTG registration is just the start of a device’s lifecycle in the Australian market.
Are you prepared for the continuous compliance requirements, post-market vigilance, and potential TGA audits that follow successful registration? Ensure you are fully equipped to manage the regulatory demands involved in the ARTG registration process for the entire life of your device.